Preclinical and Clinical Researchers play a critical role in the drug development process, ensuring that new treatments are both effective and safe before they reach the market. Preclinical researchers conduct studies in laboratories and animal models to gather the initial data on a drug’s safety, efficacy, and pharmacokinetics. These early-stage studies help identify the potential risks and benefits of a drug, as well as the optimal dosage and administration routes. Preclinical research serves as the foundation for clinical trials, where drugs are tested in human subjects for the first time. Preclinical studies are essential for laying the groundwork for clinical research, ensuring that only the most promising candidates advance to human testing.
After passing preclinical testing, clinical researchers take over to lead trials in human volunteers and patients. Clinical researchers are responsible for designing and conducting clinical trials, which are divided into phases to evaluate the drug’s safety, effectiveness, and long-term impacts. Clinical researchers ensure that all trials are conducted ethically and in compliance with regulatory guidelines, gathering critical data to support drug approval by regulatory agencies. By analyzing data from clinical trials, these researchers provide vital information that helps determine whether a drug can be approved for widespread use. As the demand for more personalized and targeted therapies grows, preclinical and clinical researchers are essential in transforming scientific discoveries into real-world treatments that benefit patients globally.
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Exploring classical ayurvedic drugs in hypertension
Prashant Bhokardankar, Datta Meghe Ayurved College, India
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model based on design-inspired biotech- & biopharma-driven applications to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : A unique role and and impact of catalytic antibodies (abzymes) in clinical practice: A novel strategy for predicting and preventing relapse in chronic autoimmune conditions
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promise of nanotechnology in personalized & precision medicine: Drug discovery & development being partnered with nanotechnologies via the revolution at the nanoscale
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : The promising future of the unique translational tool to manage beta-cell population renewal and regeneration to secure the post-diabetic period
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Easily injectable, organic solvent free self assembled hydrogel platform for endoscope mediated gastrointestinal polypectomy
Hitasha Vithalani , IIT Gandhinagar, India